June 20 - 22, 2011 Next Generation Protein Therapeutics Summit Hyatt at Fisherman's Wharf San Francisco, CA
Paul Watt Chairperson for "Beyond Antibodys" segment putting forward the opening remarks then passing it off to Mediimune for the first presentation.
Richard Hopkins with the first presentation after the break
Phenotypic Screening of Phylomer Libraries to Discover and Validate Targets
Phylomers are a new class of peptide, derived from genomic fragments of biodiverse archael and bacterial species, which encode structural motifs which have evolved within thermostable proteins. Phylomers have been identified with potent activity against diverse classes of intracellular targets and extracellular targets. The enormous structural diversity allows for direct phenotypic screening in mammalian or bacterial cells. Unlike the complementary technique of siRNA interference, protein interference operates at the protein level and therefore can be used to map vulnerable interfaces on potential target proteins which could provide opportunities for therapeutic intervention with peptides or other molecules.
Richard Hopkins, Ph.D., Vice President, Research, Phylogica Ltd., Australia
Anyway probably a good outcome having no news as of yet looking at the fear in markets overall.
Have a great weekend
PYC Price at posting:
6.8¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)